8-K: HCA Healthcare Reports Q3 2026 Results, Dividend Declared

HCA Healthcare announced third quarter 2026 results, with revenues up 3.6% to $19.85 billion, while net income saw a slight decrease, and declared a quarterly dividend of $0.78 per share.

Summary

• HCA Healthcare reported third quarter 2026 results, with revenues increasing by 3.6% to $19.849 billion compared to the prior year.
• Net income attributable to HCA Healthcare, Inc. decreased by 3.9% to $1.579 billion.
• Diluted earnings per share rose by 4.5% to $7.27, and adjusted diluted earnings per share increased by 3.7% to $7.22.
• Adjusted EBITDA grew by 1.2% to $3.918 billion.
• Same facility admissions increased by 2.7%, and equivalent admissions rose by 3.0%.
• The company experienced an unfavorable payer mix shift, estimated to have impacted income before taxes by approximately $400 million.
• HCA Healthcare now expects full-year operating results to be in the upper half of its previously issued guidance ranges.
• The Board of Directors declared a quarterly cash dividend of $0.78 per share, payable on December 29, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed but generally stable performance, with revenue growth and strong cash flow offset by a decline in net income and challenges from payer mix shifts.

Positives

• Revenue growth of 3.6% to $19.849 billion in the third quarter.
• Same facility admissions increased by 2.7% and equivalent admissions by 3.0%.
• Same facility emergency room visits increased by 5.1%.
• Adjusted EBITDA increased by 1.2% to $3.918 billion.
• Cash flows from operating activities were strong at $4.461 billion for the quarter.
• The company expects full-year operating results to be in the upper half of its guidance.
• A quarterly cash dividend of $0.78 per share was declared.

Negatives

• Net income attributable to HCA Healthcare, Inc. declined by 3.9% to $1.579 billion.
• Same facility inpatient surgeries declined by 1.4%, and outpatient surgeries by 3.7%.
• An unfavorable payer mix shift, primarily due to increased uninsured volume, negatively impacted income before taxes by an estimated $400 million.
• Adjusted EBITDA margin decreased to 19.7% from 20.2% in the prior year's third quarter.

Risks

• Changes in general economic or business conditions, including inflation and trade policies.
• Impact of current and future health care public policy developments and regulatory changes.
• Expiration of enhanced premium tax credits (EPTCs) at the end of 2025.
• Ability to achieve operating and financial targets and control costs.
• Impact of significant indebtedness and ability to refinance.
• Potential for increased expenses related to labor, pharmaceuticals, and supply chain disruptions.
• Increases in the amount and risk of collectability of uninsured accounts and deductibles.
• Highly competitive nature of the health care business.

Future Outlook

The Company now believes its full year operating results for 2026 will be in the upper half of its previously issued guidance ranges, based on current plans and expectations, but subject to known and unknown uncertainties and risks.

Management Comments

• "I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and our disciplined culture. Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively."
• Sam Hazen, Chief Executive Officer of HCA Healthcare.

Industry Context

StockSavvy.ai notes that HCA Healthcare's results reflect broader industry pressures, including shifts in payer mix and the ongoing impact of federal policy changes, while demonstrating resilience through revenue growth and operational improvements in key areas.

Stakeholder Impact

• Shareholders: Benefit from a declared quarterly cash dividend of $0.78 per share.
• Employees: Continued provision of high-quality care to patients despite challenges.
• Communities: HCA plays an important role in providing critical services.
• Patients: Experience care delivery amidst evolving healthcare policies and payer dynamics.

Next Steps

• Continue to monitor and manage the impact of federal policy changes and payer mix shifts.
• Execute on resiliency initiatives to offset potential impacts.
• Focus on achieving full-year operating results within the updated guidance range.

Key Dates

Recommendation

The filing presents a mixed financial picture with revenue growth and strong cash flow, but a decline in net income due to payer mix shifts. The company's outlook is cautiously optimistic, expecting to meet the upper half of guidance. The declared dividend is positive, but the ongoing risks and the slight dip in profitability suggest a 'hold' rating until clearer signs of sustained net income recovery emerge.

Keywords

healthcare, hospital, revenue, earnings, EBITDA, admissions, dividend, payer mix